,title,source,link,date
35,Stock Market Live Updates: Losses in IT and finance weigh on Indian markets; retail inflation data awaited,BusinessLine,news.google.com/articles/CBMieGh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3NoYXJlLW1hcmtldC1zZW5zZXgtbmlmdHktbGl2ZS11cGRhdGVzLTEzLW5vdmVtYmVyLTIwMjMvYXJ0aWNsZTY3NTI3NDAzLmVjZdIBfWh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3NoYXJlLW1hcmtldC1zZW5zZXgtbmlmdHktbGl2ZS11cGRhdGVzLTEzLW5vdmVtYmVyLTIwMjMvYXJ0aWNsZTY3NTI3NDAzLmVjZS9hbXAv?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-13
1,Diwali Muhurat Trading 2023: Glenmark Pharma share price opens almost 10% lower after Q2 result | Mint,Mint,news.google.com/articles/CBMiowFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL2Rpd2FsaS1tdWh1cmF0LXRyYWRpbmctMjAyMy1nbGVubWFyay1waGFybWEtc2hhcmUtcHJpY2Utb3BlbnMtYWxtb3N0LTEwLWxvd2VyLWFmdGVyLXEyLXJlc3VsdC0xMTY5OTc5NDU4MTI0NC5odG1s0gGnAWh0dHBzOi8vd3d3LmxpdmVtaW50LmNvbS9tYXJrZXQvc3RvY2stbWFya2V0LW5ld3MvZGl3YWxpLW11aHVyYXQtdHJhZGluZy0yMDIzLWdsZW5tYXJrLXBoYXJtYS1zaGFyZS1wcmljZS1vcGVucy1hbG1vc3QtMTAtbG93ZXItYWZ0ZXItcTItcmVzdWx0L2FtcC0xMTY5OTc5NDU4MTI0NC5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-12
0,Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24,PSU Watch,news.google.com/articles/CBMiTWh0dHBzOi8vcHN1d2F0Y2guY29tL25ld3N1cGRhdGVzL3ByZXNzLXJlbGVhc2UvZ2xlbm1hcmstcGhhcm1hY2V1dGljYWxzLWx0ZC0y0gFXaHR0cHM6Ly9wc3V3YXRjaC5jb20vYW1wL3N0b3J5L25ld3N1cGRhdGVzL3ByZXNzLXJlbGVhc2UvZ2xlbm1hcmstcGhhcm1hY2V1dGljYWxzLWx0ZC0y?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
2,India's Glenmark Pharma posts Q2 loss on exceptional legal costs,Reuters,news.google.com/articles/CBMihAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9pbmRpYXMtZ2xlbm1hcmstcGhhcm1hLXBvc3RzLXEyLWxvc3MtZXhjZXB0aW9uYWwtbGVnYWwtY29zdHMtMjAyMy0xMS0xMC_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
36,"Active Pharmaceutical Ingredients (API) Market Outlook 2028, the ...",Medgadget,news.google.com/articles/CBMiswFodHRwczovL3d3dy5tZWRnYWRnZXQuY29tLzIwMjMvMTEvYWN0aXZlLXBoYXJtYWNldXRpY2FsLWluZ3JlZGllbnRzLWFwaS1tYXJrZXQtb3V0bG9vay0yMDI4LXRoZS1tYXJrZXQtdG8td2l0bmVzcy1pbnZlc3RtZW50LW9mLXVzZC0zMTItMzctYmlsbGlvbi1pbi10aGUtbmV4dC02LXllYXJzLWFyaXp0b24uaHRtbNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
17,India's pharma and healthcare sectors maintain investment appeal ...,The Pharma Letter,news.google.com/articles/CBMif2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9pbmRpYS1zLXBoYXJtYS1hbmQtaGVhbHRoY2FyZS1zZWN0b3JzLW1haW50YWluLWludmVzdG1lbnQtYXBwZWFsLWRlc3BpdGUtdm9sdW1lLWRlY2xpbmXSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-08
73,"Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr",Business Standard,news.google.com/articles/CBMihQFodHRwczovL3d3dy5idXNpbmVzcy1zdGFuZGFyZC5jb20vY29tcGFuaWVzL25ld3MvZXJpcy10by1idXktZGVybWEtbmVwaHJvLXVuaXRzLW9mLWJpb2Nvbi1iaW9sb2dpY3MtZm9yLXJzLTM2Ni1jci0xMjMxMTA4MDA4MTlfMS5odG1s0gGJAWh0dHBzOi8vd3d3LmJ1c2luZXNzLXN0YW5kYXJkLmNvbS9hbXAvY29tcGFuaWVzL25ld3MvZXJpcy10by1idXktZGVybWEtbmVwaHJvLXVuaXRzLW9mLWJpb2Nvbi1iaW9sb2dpY3MtZm9yLXJzLTM2Ni1jci0xMjMxMTA4MDA4MTlfMS5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-08
9,Pharma and healthcare sectors thrive despite dip in deal volume in Q3CY23,Business Today,news.google.com/articles/CBMijAFodHRwczovL3d3dy5idXNpbmVzc3RvZGF5LmluL2xhdGVzdC90cmVuZHMvc3RvcnkvcGhhcm1hLWFuZC1oZWFsdGhjYXJlLXNlY3RvcnMtdGhyaXZlLWRlc3BpdGUtZGlwLWluLWRlYWwtdm9sdW1lLWluLXEzY3kyMy00MDM5NjEtMjAyMy0xMC0zMdIBkAFodHRwczovL3d3dy5idXNpbmVzc3RvZGF5LmluL2FtcC9sYXRlc3QvdHJlbmRzL3N0b3J5L3BoYXJtYS1hbmQtaGVhbHRoY2FyZS1zZWN0b3JzLXRocml2ZS1kZXNwaXRlLWRpcC1pbi1kZWFsLXZvbHVtZS1pbi1xM2N5MjMtNDAzOTYxLTIwMjMtMTAtMzE?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-31
